Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kyle

Showing results (841-850 of 874) with videos related to

Pageof 88
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|March 24, 2026
ALARA+: Summit on Radiation and Orthopedic Risks in Fluoroscopic Laboratories: Endorsed by ACC, ACVP, ASE, HRS, SCAI, SIR, SNIS, SVIN, and SVSArash Salavitabar, Amit N Vora, Dorothea Altschul, et al.
Blood Advances|April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL AmyloidosisMaximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Mayo Clinic Proceedings|April 2, 2013
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013Joseph R Mikhael, David Dingli, Vivek Roy, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|May 11, 2026
ALARA+: Summit on Radiation and Orthopedic Risks in Fluoroscopic LaboratoriesArash Salavitabar, Amit N Vora, Dorothea Altschul, et al.
Journal of Medicinal Chemistry|March 15, 2000
Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activityM R Wiley, L C Weir, S Briggs, et al.
American Journal of Hematology|January 11, 2021
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohortMaria Eleni Drosou, Lisa E Vaughan, Eli Muchtar, et al.
Heart Rhythm|March 26, 2026
ALARA+: Summit on Radiation and Orthopedic Risks in Fluoroscopic LaboratoriesArash Salavitabar, Amit N Vora, Dorothea Altschul, et al.
Blood|March 27, 2004
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantationAngela Dispenzieri, Morie A Gertz, Robert A Kyle, et al.
American Journal of Hematology|April 28, 2021
Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemiaJithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Infant gut microbiomes contribute to metabolic states that impact brain functionFiras S Midani, Do-Hun Lee, Younghye Moon, et al.
Pageof 88

Showing results (841-850 of 874) with videos related to

Sort By:
Pageof 88
Journal of Vascular and Interventional Radiology : JVIR|March 24, 2026
ALARA+: Summit on Radiation and Orthopedic Risks in Fluoroscopic Laboratories: Endorsed by ACC, ACVP, ASE, HRS, SCAI, SIR, SNIS, SVIN, and SVSArash Salavitabar, Amit N Vora, Dorothea Altschul, et al.
Blood Advances|April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL AmyloidosisMaximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Mayo Clinic Proceedings|April 2, 2013
Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013Joseph R Mikhael, David Dingli, Vivek Roy, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|May 11, 2026
ALARA+: Summit on Radiation and Orthopedic Risks in Fluoroscopic LaboratoriesArash Salavitabar, Amit N Vora, Dorothea Altschul, et al.
Journal of Medicinal Chemistry|March 15, 2000
Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activityM R Wiley, L C Weir, S Briggs, et al.
American Journal of Hematology|January 11, 2021
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohortMaria Eleni Drosou, Lisa E Vaughan, Eli Muchtar, et al.
Heart Rhythm|March 26, 2026
ALARA+: Summit on Radiation and Orthopedic Risks in Fluoroscopic LaboratoriesArash Salavitabar, Amit N Vora, Dorothea Altschul, et al.
Blood|March 27, 2004
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantationAngela Dispenzieri, Morie A Gertz, Robert A Kyle, et al.
American Journal of Hematology|April 28, 2021
Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemiaJithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Infant gut microbiomes contribute to metabolic states that impact brain functionFiras S Midani, Do-Hun Lee, Younghye Moon, et al.
Pageof 88